Journal Article NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs

Ichise, Hiroshi  ,  Nagano, Seiji  ,  Maeda, Takuya  ,  Miyazaki, Masaki  ,  Miyazaki, Yuki  ,  Kojima, Hiroto  ,  Yawata, Nobuyo  ,  Yawata, Makoto  ,  Tanaka, Hidenori  ,  Saji, Hiroh  ,  Masuda, Kyoko  ,  Kawamoto, Hiroshi

92017-08-31 , Elsevier BV
ISSN:2213-6711
Description
iPS細胞から再生した細胞への免疫反応とその制御法 --今後のストック事業で起こりうる拒絶反応への対処法を提案--. 京都大学プレスリリース. 2017-09-01.
HLA haplotype-homozygous (HLA-homo) induced pluripotent stem cells (iPSCs) are being prepared to be used for allogeneic transplantation of regenerated tissue into recipients carrying an identical haplotype in one of the alleles (HLA-hetero). However, it remains unaddressed whether natural killer (NK) cells respond to these regenerated cells. HLA-C allotypes, known to serve as major ligands for inhibitory receptors of NK cells, can be classified into group 1 (C1) and group 2 (C2), based on their binding specificities. We found that the T cells and vascular endothelial cells regenerated from HLA-homo-C1/C1 iPSCs were killed by specific NK cell subsets from a putative HLA-hetero-C1/C2 recipient. Such cytotoxicity was canceled when target cells were regenerated from iPSCs transduced with the C2 gene identical to the recipient. These results clarify that NK cells can kill regenerated cells by sensing the lack of HLA-C expression and further provide the basis for an approach to prevent such NK cell-mediated rejection responses.
Full-Text

http://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/226956/1/j.stemcr.2017.07.020.pdf

Number of accesses :  

Other information